QCL-105483 (MOT114136)

• Research type

  Research Study

• Full title

  An open label, single sequence study to evaluate the pharmacokinetics and absolute bioavailability of GSK962040 given as an oral dose simultaneously with an intravenous microtracer dose of [14C]-GSK962040 in healthy male volunteers. QCL - 105483

• IRAS ID

  53687

• Contact name

  Joanne Collier

• Sponsor organisation

  GlaxoSmithKline Research and Development Limited

• Eudract number

  2010-020409-34

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  The purpose of the study is to look at how GSK962040 is taken up by the body when given by mouth and by injection. The drug is a new experimental drug being developed by the sponsor company, GlaxoSmithKline, for the potential treatment of conditions associated with slow rates of stomach emptying (for example for patients who have slow emptying from the stomach because of diabetes). This study is being carried out on behalf of GlaxoSmithKline.

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  10/IEC04/6

• Date of REC Opinion

  8 Jun 2010

• REC opinion

  Favourable Opinion